PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) Zimbabwe · MCAZ

MAINTELYTE

MAINTELYTE

2004/23.2.1/4242 SOLUTION; INJECTION 2.05; 1.86; 0.51G

What it does

Maintelyte is a medication used to help maintain the balance of fluids and electrolytes in the body.

Commonly used for: dehydration, electrolyte imbalance

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
2004/23.2.1/4242
Registration date
2004-02-10
Expiry date
2027-12-31
Status
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
Active ingredient
MAINTELYTE
Dosage form
SOLUTION; INJECTION
Strength
2.05; 1.86; 0.51G
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Datlabs
Applicant / LTR
DATLABS PRIVATE LIMITED
Country of origin
-
Manufacturer location
45 Falcon St, Bulawayo, Zimbabwe

Source: Medicines Control Authority of Zimbabwe · fetched 2026-04-18 08:22:08 · updated 2026-10-21 04:30:07

Disclaimer: This information is sourced from Medicines Control Authority of Zimbabwe (Zimbabwe). Always consult a qualified healthcare professional before using any medication.

About this medicine

Maintelyte is a medication used to help maintain the balance of fluids and electrolytes in the body.

What it treats

  • dehydration
  • electrolyte imbalance

How it works

Maintelyte provides important minerals and fluids that help keep the body's systems functioning properly.

Who it's for

It is suitable for people who have lost fluids due to conditions like diarrhea, vomiting, or heavy sweating.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: maintelyte

Maintelyte is an oral rehydration solution that is formulated to restore electrolyte balance in individuals who have lost fluids due to conditions such as diarrhea or vomiting. It contains a balanced concentration of electrolytes, including sodium, potassium, and glucose, which are crucial for maintaining hydration and proper physiological function.

Indications

  • Dehydration due to diarrhea
  • Dehydration due to vomiting
  • Electrolyte imbalance
  • Rehydration therapy in children and adults

Dosage

Children: Refer to specific guidelines for children, adjusting the volume based on age and degree of dehydration.

Adults: Refer to specific guidelines for adults, typically involving the administration of oral rehydration solutions based on the severity of dehydration.

Mechanism of action

Maintelyte works by facilitating the absorption of water and electrolytes in the intestines. The presence of glucose enhances sodium absorption through the sodium-glucose co-transport mechanism, improving hydration status in patients experiencing dehydration due to fluid loss.

Pharmacodynamics

Maintelyte helps to replace lost fluids and electrolytes, thereby restoring osmotic balance and preventing complications associated with dehydration. The combination of sodium and glucose in the solution also promotes efficient rehydration, leading to rapid recovery from dehydration.

Pharmacokinetics

The components of Maintelyte are rapidly absorbed in the gastrointestinal tract. Sodium and glucose absorption occurs primarily in the small intestine, while potassium and other electrolytes are absorbed as needed. The onset of action is typically within hours, depending on the severity of dehydration and the volume of solution administered.

Contra-indications

  • Hypersensitivity to any component of the formulation
  • Severe renal impairment
  • Hyperkalemia
  • Uncorrected adrenal insufficiency

Adverse effects

  • Electrolyte imbalances
  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal cramps
  • Flatulence

Interactions

  • Potassium-sparing diuretics may increase the risk of hyperkalemia when used concurrently
  • ACE inhibitors and angiotensin II receptor blockers may also increase potassium levels
  • Corticosteroids may affect electrolyte balance when administered with Maintelyte

Precautions

  • Use with caution in patients with renal impairment
  • Monitor electrolyte levels during prolonged use
  • Assess for underlying conditions that may affect electrolyte balance
  • Consider potential gastrointestinal disturbances

Pregnancy

Maintelyte should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare professional.

Breast-feeding

Caution is advised when administering to breastfeeding mothers. Monitor for any adverse effects in the infant.

Storage

Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.

Formulations

  • Oral solution
  • Powder for reconstitution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.